The aim of our study is to investigate the safety of terbinafine usage in pregnancy. This study was designed to investigate the teratogenic effects of prenatal terbinafine exposure in newborn rats in terms of macroscopic organ anomalies, anthropometric scales and abnormalities in skin development. Female Wistar-Albino rats (250-300 g) were randomly divided into a control group (physiological saline, during pregnancy; n=6), group A (terbinafine treatment, 20 mg/kg/day, for 21 days; n=6), group B (terbinafine treatment, 20 mg/kg/day, for 51 days; n=6) and group C (terbinafine treatment, 60 mg/kg/day, for 21 days; n=6). After birth, five rat pups from each experimental group were sacrificed by intracardiac infusion of 10% formalin. Skin biopsies were performed from the abdominal region and prepared for light microscopic analysis. Hyperkeratosis, epidermal atrophy and disordered epidermal cell lineage were demonstrated in all terbinafine doses with increase in severity at higher doses. Damage to hair follicles was observed in groups B and C. In conclusion, terbinafine exposure during pregnancy can cause abnormalities of the skin and growth retardation in newborn rats, and the effects vary depending upon application time and dose.
INTRODUCTION
rug usage has been documented more commonly during the first and third trimesters, which exposes the fetus to teratogenic effects during the critical period of organogenesis (1, 2) . Since no drug administered during pregnancy has been proved to be entirely free of adverse effects concerning well-being of the fetus, great caution should be taken for prescribing drugs during pregnancy to prevent the potential teratogenicity.
However, difficulties in testing novel agents in pregnant women as well as a paucity of research have complicated the clarification of drug use during pregnancy when compared to other therapeutic measures (3).
Defined as structural or functional dysgenesis of the fetal organs (4), teratogenesis consists of congenital malformations with varying severity, including intrauterine growth restriction, carcinogenesis and fetal demise. Hence, an understanding of the mechanisms underlying teratogenicity is crucial to estimate the potential risk of a certain drug to produce congenital malformations (3) as well as to optimize drug use by pregnant women who have been reported to take many medications besides vitamin supplements or iron, despite a growing awareness of the need to avoid drugs (5, 6) .
As an allylamine that inhibits squalene epoxidase leading to intracellular accumulation of squalene, which is lethal to fungal cells, terbinafine represented a major advance in the therapy for onychomycosis owing to rapid eradication of difficult-to-kill organisms at much lower drug concentrations than other anti-fungal agents (7).
Terbinafine has not been reported with any teratogenic changes in rats or rabbits, however, to our knowledge, there are no studies available regarding its use in human pregnancy (8) . It has been classified by the FDA as a pregnancy category B agent, which is less restrictive than the classification assigned to itraconazole (7) and is excreted in breast milk (9) .
Terbinafine was first introduced in the UK in February 1991 and was approved for the treatment of onychomycosis in the US in May 1996 (3, 8, 9) .
Since then, terbinafine has been used widely for the effective treatment of superficial candidiasis (8, 9) .
Owing to the presence of limited data on the adverse-effects profile of oral terbinafine in pregnancy (9), use of terbinafine during pregnancy has been suggested to be avoided (3). Since terbinafine has been known to distribute and also accumulate in nails, epidermis, dermis and adipose tissue, the present study was designed to investigate the possible teratogenic effects of prenatal terbinafine exposure in newborn rats in terms of macroscopic organ anomalies, anthropometric scales and abnormalities in skin development. hours before tissue processing.
MATERIALS and METHODS

Animals
Histopathological Procedures
The study included formalin-fixed, paraffin wax embedded skin tissue samples from control and experimental groups. Routine paraffin wax embedding procedures were used. In brief, tissue samples were fixed in 10% formalin, dehydrated in a graded ethanol series, cleared in xylene, embedded in paraffin wax and 5 mm thick sections were cut.
The tissue sections were stained with Haematoxylin and Eosin (H&E) for histological assessment under an Olympus BX 50 bright-field microscope (Olympus, Tokyo, Japan) and photographed using Kodak ISO 400 film.
Preparation of the Experimental Drug
Terbinafine-HCl solution (25 mg/ml) was freshly prepared by dissolution of 250 mg tablet form in 10 ml distilled water and given in 20 mg/kg and 60 mg/kg doses according to experimental groups.
Vaginal Smear Method
After 11 hours incubation with a common male partner, each pair of female rats was separated to evaluate the presence of sperm in the vaginal smear as a reliable indicator of mating, after which terbinafine was initiated.
Statistical Analysis
Statistical analysis was made using SPSS statistical software (version 10.0, SPSS Inc. Chicago, IL). Experimental groups were compared statistically using Chi-square ( 
RESULTS
Macroscopic Findings
Macroscopic observation of the rat pups did Table   1 ). The most significant reduction in body weight was observed in group C (P<0.001; Table 1 ).
Histopathological Findings
Histological analysis of abdominal skin samples revealed the normal epidermis and dermis layers of the skin in the control group. The epidermis was composed of stratified squamous epithelium and was seen in its normal thickness. The border between the epidermis and dermis was clearly
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demarcated. The underlying papillary layer of the dermis had abundant capillaries and connective tissue cells, whereas the reticular layer of the dermis was composed of a denser connective tissue rich in collagen fibers (Fig 1a, b) . Histological analysis of abdominal skin samples A revealed hyperkeratotic stratum corneum (Fig 1d) and atrophic epidermis with mild spongiosis in group A (Fig 1c, d ) and marked hyperkeratosis and significant atrophy in the epidermis in group B (Fig 2a, b) .
Additionally, marked irregularity in the cell lineage and structural abnormalities in the hair follicles with fibrotic tissue increase in the dermis and hair follicles were determined in group A and B (Fig 2a,   b) . In group C, there was marked hyperkeratosis, abnormal cell lineage and striking endometrial atrophy with structural abnormalities in the epidermal cells (Fig 2c) . Hyperchromatic appearance of dysplastic epidermal cells with pronounced dysplasia and, structural abnormalities in the hair follicles with fibrotic tissue increase in the dermis and hair follicles were also determined in group C (Fig 2c, d ) Hyperkeratosis demonstrated in all of our experimental groups including prenatal terbinafine administration, has been considered as a wellknown integumentary reaction of a fetus to foreign external agents administered during pregnancy (22) (23) (24) . Furthermore, epidermal atrophy observed in all of the rat pups exposed to terbinafine in our study was also shown in experimental intrauterine growth retardation models in the skins of newborn rats (25) . Indicating dose-dependent deterioration of skin development, damage to hair follicles was observed in groups B and C while appearance of hyperchromatic and dysplastic cells was specific to group C rats exposed to the highest dose (60 mg/kg) of terbinafine in our study. 
